author-photo

Natalia Manilo

Frederiksberg Hospital

23

Papers

468

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry

2021 Scandinavian Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Association between MRI findings and patient‐reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse

2020 International Journal of Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (3)
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

2018 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: Possible fallout on non-medical switching' by Cantini and Benucci

2018 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (2)
THU0189 One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the danbio registry

2018 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
One-year treatment retention after a nationwide nonmedical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry

2018 Scandinavian journal of rheumatology. Supplement
Show All
- Source
- Cite
- Save
Citations (0)
FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

2017 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (19)
One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept: – an Observational Study from the Danish Danbio Registry

2017 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (13)
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

2017 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (160)
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

2017 Clinical Epidemiology
Show All
- Source
- Cite
- Save
Citations (34)